Endonovo Therapeutics
Phase 1Endonovo Therapeutics (OTCQB: ENDV) is a commercial stage developer of non-invasive medical devices designed to deliver its proprietary Electroceutical® Therapy for the treatment of inflammatory conditions, cardiovascular diseases and central nervous system disorders.
Founded
2012
Focus
Regenerative MedicineCell Therapy
About
Endonovo Therapeutics (OTCQB: ENDV) is a commercial stage developer of non-invasive medical devices designed to deliver its proprietary Electroceutical® Therapy for the treatment of inflammatory conditions, cardiovascular diseases and central nervous system disorders.
Company Info
TypePrivate
Founded2012
LocationCulver City, United States
StagePhase 1
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile